0000899243-19-017955.txt : 20190624
0000899243-19-017955.hdr.sgml : 20190624
20190624170419
ACCESSION NUMBER: 0000899243-19-017955
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190620
FILED AS OF DATE: 20190624
DATE AS OF CHANGE: 20190624
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McGeorge Anne
CENTRAL INDEX KEY: 0001779934
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38541
FILM NUMBER: 19916068
MAIL ADDRESS:
STREET 1: C/O MAGENTA THERAPEUTICS, INC.
STREET 2: 100 TECHNOLOGY SQUARE, 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Magenta Therapeutics, Inc.
CENTRAL INDEX KEY: 0001690585
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 TECHNOLOGY SQUARE
STREET 2: 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-201-2700
MAIL ADDRESS:
STREET 1: 100 TECHNOLOGY SQUARE
STREET 2: 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-20
0
0001690585
Magenta Therapeutics, Inc.
MGTA
0001779934
McGeorge Anne
C/O MAGENTA THERAPEUTICS, INC.
100 TECHNOLOGY SQUARE
CAMBRIDGE
MA
02139
1
0
0
0
Stock Option (Right to Buy)
14.94
2019-06-20
4
A
0
36377
0.00
A
2029-06-19
Common Stock
36377
36377
D
This option shall vest and become exercisable over three years, with 33% of this option vesting on June 20, 2020, and the remainder vesting in 24 equal monthly installments thereafter.
/s/ Zoran Zdraveski, Attorney-in-Fact for Anne McGeorge
2019-06-24